| 2024-04-09 17:15 | CC:COOL | Core One Labs Inc (3) | 0.21 | News Release200 | Core One Labs arranges $1.5-million private placement |
| 2024-02-29 12:47 | CC:COOL | Core One Labs Inc (3) | 0.24 | SEDAR Interim Financial Statements812 | SEDAR Interim Financial Statements |
| 2024-02-29 12:47 | CC:COOL | Core One Labs Inc (3) | 0.24 | SEDAR Interim MD & A813 | SEDAR Interim MD & A |
| 2024-01-22 19:50 | CC:COOL | Core One Labs Inc (3) | 0.30 | News Release200 | Core One to issue 368,571 shares for debt |
| 2023-12-08 19:02 | CC:COOL | Core One Labs Inc (3) | 0.385 | News Release200 | Core One signs deal for potential sale of psilocybin |
| 2023-12-01 19:18 | CC:COOL | Core One Labs Inc (3) | 0.24 | News Release200 | Core One finds CL2006 motility in animal studies |
| 2023-11-03 18:11 | CC:COOL | Core One Labs Inc (3) | 0.22 | SEDAR Interim Financial Statements812 | SEDAR Interim Financial Statements |
| 2023-11-03 18:11 | CC:COOL | Core One Labs Inc (3) | 0.22 | SEDAR Interim MD & A813 | SEDAR Interim MD & A |
| 2023-09-18 12:10 | CC:COOL | Core One Labs Inc (3) | 0.425 | News Release200 | Core One Labs closes $200,000 private placement |
| 2023-09-11 16:14 | CC:COOL | Core One Labs Inc (3) | 0.37 | News Release200 | Core One Labs arranges $1-million private placement |
| 2023-08-29 12:57 | CC:COOL | Core One Labs Inc (3) | 0.38 | SEDAR Interim MD & A813 | SEDAR Interim MD & A |
| 2023-08-29 12:54 | CC:COOL | Core One Labs Inc (3) | 0.38 | SEDAR Interim Financial Statements812 | SEDAR Interim Financial Statements |
| 2023-08-23 19:25 | CC:COOL | Core One Labs Inc (3) | 0.44 | News Release200 | Core One cheers study on psychedelics for chronic pain |
| 2023-08-04 19:33 | CC:COOL | Core One Labs Inc (3) | 0.57 | News Release200 | Core One cheers round 2 of stage 1 animal study results |
| 2023-08-03 19:16 | CC:COOL | Core One Labs Inc (3) | 0.52 | News Release200 | Core One cheers study on psilocybin for anorexia |
| 2023-08-03 14:27 | CC:COOL | Core One Labs Inc (3) | 0.58 | SEDAR Audited Annual Financial Statements804 | SEDAR Audited Annual Financial Statements |
| 2023-08-01 20:00 | CC:COOL | Core One Labs Inc (3) | 0.56 | News Release200 | Core One subsidiary Awakened files U.S. patent |
| 2023-07-28 19:35 | CC:COOL | Core One Labs Inc (3) | 0.50 | News Release200 | Core One's Akome releases stage 1 animal study results |
| 2023-07-21 19:07 | CC:COOL | Core One Labs Inc (3) | 0.52 | News Release200 | Core One's GMP to supply psychedelics to Zollaris |
| 2023-07-19 17:03 | CC:COOL | Core One Labs Inc (3) | 0.48 | News Release200 | Core One cheers California committee psychedelics bill |
| 2023-07-11 20:10 | CC:COOL | Core One Labs Inc (3) | 0.435 | News Release200 | Core One adds bioreactor to psilocybin production plan |
| 2023-07-07 18:02 | CC:COOL | Core One Labs Inc (3) | 0.445 | News Release200 | Core files int'l psilocybin production method patent |
| 2023-07-04 18:28 | CC:COOL | Core One Labs Inc (3) | 0.365 | News Release200 | Core One cheers Australia for clinical-use psychedelics |
| 2023-06-26 19:04 | CC:COOL | Core One Labs Inc (3) | 0.375 | News Release200 | Core One cheers FDA's guidance for psychedelic trials |
| 2023-05-05 19:42 | CC:COOL | Core One Labs Inc (3) | 0.49 | News Release200 | Core One in talks with companies to supply psilocybin |
| 2023-05-01 20:47 | CC:COOL | Core One Labs Inc (3) | 0.445 | News Release200 | Core One to start developing psychedelic prodrugs |
| 2023-04-21 20:05 | CC:COOL | Core One Labs Inc (3) | 0.395 | News Release200 | Core One unit completes psilocin synthetic production |